Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1630]

Erlotinib for neoadjuvant treatment of EGFR NSCLC

Dr Wen-Zhao Zhong - Guangdong General Hospital & Guangdong Academy of Medical...

Erlotinib for neoadjuvant treatment of EGFR NSCLC ( Dr Wen-Zhao Zhong - Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China )

AURA 3: Mechanisms of osimertinib resistance in patients with EGFR T790M...

Dr Vassiliki A. Papadimitrakopoulou - University of Texas MD Anderson Cancer...

AURA 3: Mechanisms of osimertinib resistance in patients with EGFR T790M advanced NSCLC ( Dr Vassiliki A. Papadimitrakopoulou - University of Texas MD Anderson Cancer Center, Houston, USA )

20 year followup on high-dose chemo with HSCT in high-risk breast cancer

Dr Tessa Steenbruggen - Netherlands Cancer Institute, Amsterdam, Netherlands

20 year followup on high-dose chemo with HSCT in high-risk breast cancer ( Dr Tessa Steenbruggen - Netherlands Cancer Institute, Amsterdam, Netherlands )

Opportunities for biosimilars in practice and education

Prof Diana Lüftner- Humboldt University, Berlin, Germany

Opportunities for biosimilars in practice and education ( Prof Diana Lüftner- Humboldt University, Berlin, Germany )

Updates from the EMBRACA trial for advanced breast cancer

Prof Hope Rugo - University of California, San Francisco, USA

Updates from the EMBRACA trial for advanced breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )

Key developments in prostate cancer

Prof Nicholas James, Prof Karim Fizazi, Prof Matthew Smith, Prof Álvaro Pinto...

Key developments in prostate cancer ( Prof Nicholas James, Prof Karim Fizazi, Prof Matthew Smith, Prof Álvaro Pinto and Dr Mark Beresford )

Therapeutic targeting at a pre-metastatic stage for brain metastases from lung...

Dr Sheila Singh - McMaster University, Ontario, Canada

Therapeutic targeting at a pre-metastatic stage for brain metastases from lung cancer ( Dr Sheila Singh - McMaster University, Ontario, Canada )

Recent advances in CNS tumour management

Prof Joan Seoane - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Recent advances in CNS tumour management ( Prof Joan Seoane - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer

Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands

Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer ( Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands )

Updates in head and neck cancers

Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium

Updates in head and neck cancers ( Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium )

KEYNOTE022: Triplet therapy for BRAF melanoma

Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale"...

KEYNOTE022: Triplet therapy for BRAF melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy )

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell...

Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer...

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )

More from ecancer